相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients
Angelica Loskog et al.
BRITISH JOURNAL OF CANCER (2016)
Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection
Eugene A. Zhukovsky et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Immunocytokines for cancer treatment: past, present and future
Dario Neri et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
J. M. Michot et al.
EUROPEAN JOURNAL OF CANCER (2016)
Immunocytokines and bispecific antibodies: two complementary strategies for the selective activation of immune cells at the tumor site
Jonathan D. Kiefer et al.
IMMUNOLOGICAL REVIEWS (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
Metabolic reprogramming: the emerging concept and associated therapeutic strategies
Go J. Yoshida
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf
Linda Hammerich et al.
MOLECULAR ONCOLOGY (2015)
Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients
Emanuela Romano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Agonists of Co-stimulation in Cancer Immunotherapy Directed Against CD137, 0X40, GITR, CD27, CD28, and ICOS
Miguel F. Sanmamed et al.
SEMINARS IN ONCOLOGY (2015)
In-situ tumor vaccination: Bringing the fight to the tumor
Robert H. Pierce et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Kick-starting the cancer-immunity cycle by targeting CD40
P. Ellmark et al.
ONCOIMMUNOLOGY (2015)
Immunotherapies and novel combinations: the focus of advances in the treatment of melanoma
Paolo A. Ascierto
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Armed antibodies for cancer treatment: a promising tool in a changing era
Riccardo Danielli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
The Human Agonistic CD40 Antibody ADC-1013 Eradicates Bladder Tumors and Generates T-cell-Dependent Tumor Immunity
Sara M. Mangsbo et al.
CLINICAL CANCER RESEARCH (2015)
Probody therapeutics for targeting antibodies to diseased tissue
Krishna R. Polu et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
Effectiveness of slow-release systems in CD40 agonistic antibody immunotherapy of cancer
Marieke F. Fransen et al.
VACCINE (2014)
Locally Delivered CD40 Agonist Antibody Accumulates in Secondary Lymphoid Organs and Eradicates Experimental Disseminated Bladder Cancer
Linda C. Sandin et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo
Linda C. Sandin et al.
ONCOIMMUNOLOGY (2014)
Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8+ T-Cell-Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects
Marieke F. Fransen et al.
CLINICAL CANCER RESEARCH (2013)
Agonistic CD40 Antibodies and Cancer Therapy
Robert H. Vonderheide et al.
CLINICAL CANCER RESEARCH (2013)
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
Aurelien Marabelle et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma
Tyler R. Simpson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Treatment Efficacy and Immune Stimulation by AdCD40L Gene Therapy of Spontaneous Canine Malignant Melanoma
Sara Westberg et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Antitumor activities of agonistic anti-TNFR antibodies require differential FcγRIIB coengagement in vivo
Fubin Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Synergistic augmentation of CD40-mediated activation of antigen-presenting cells by amphiphilic poly(γ-glutamic acid) nanoparticles
Sissela Broos et al.
BIOMATERIALS (2012)
In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study
Youn H. Kim et al.
BLOOD (2012)
Combination of a Bispecific Antibody and Costimulatory Antibody-Ligand Fusion Proteins for Targeted Cancer Immunotherapy
Nora Hornig et al.
JOURNAL OF IMMUNOTHERAPY (2012)
The HIF-1α Hypoxia Response in Tumor-Infiltrating T Lymphocytes Induces Functional CD137 (4-1BB) for Immunotherapy
Asis Palazon et al.
CANCER DISCOVERY (2012)
Current and Potential Uses of Immunocytokines as Cancer Immunotherapy
Paul M. Sondel et al.
ANTIBODIES (2012)
A CpG-loaded tumor cell vaccine induces antitumor CD4+ T cells that are effective in adoptive therapy for large and established tumors
Matthew J. Goldstein et al.
BLOOD (2011)
An Fcγ Receptor-Dependent Mechanism Drives Antibody-Mediated Target-Receptor Signaling in Cancer Cells
Nicholas S. Wilson et al.
CANCER CELL (2011)
Local Activation of CD8 T Cells and Systemic Tumor Eradication without Toxicity via Slow Release and Local Delivery of Agonistic CD40 Antibody
Marieke F. Fransen et al.
CLINICAL CANCER RESEARCH (2011)
Interaction with FcγRIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody
Ann L. White et al.
JOURNAL OF IMMUNOLOGY (2011)
AdCD40L Immunogene Therapy for Bladder Carcinoma-The First Phase I/IIa Trial
Per-Uno Malmstrom et al.
CLINICAL CANCER RESEARCH (2010)
Local AdCD40L Gene Therapy is Effective for Disseminated Murine Experimental Cancer by Breaking T-cell Tolerance and Inducing Tumor Cell Growth Inhibition
Camilla Lindqvist et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Deliberately provoking local inflammation drives tumors to become their own protective vaccine site
Connie Jackaman et al.
INTERNATIONAL IMMUNOLOGY (2008)
Efficient adenovector CD40 ligand immunotherapy of canine malignant melanoma
Henrik von Euler et al.
JOURNAL OF IMMUNOTHERAPY (2008)
A novel antibody-4-1 BBL fusion protein for targeted costimulation in cancer immunotherapy
Dafne Mueller et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses
Sebastian Tuve et al.
CANCER RESEARCH (2007)
CD40 stimulation leads to effective therapy of CD40-tumors through induction of strong systemic cytotoxic T lymphocyte immunity
GJD van Mierlo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Potent antitumor effects of CD154 transduced tumor cells in experimental bladder cancer
A Loskog et al.
JOURNAL OF UROLOGY (2001)
分享论文
